320 related articles for article (PubMed ID: 3293970)
1. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.
Prandota J
Drugs; 1988 May; 35(5):542-78. PubMed ID: 3293970
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.
Touw DJ
Pharm World Sci; 1998 Aug; 20(4):149-60. PubMed ID: 9762727
[TBL] [Abstract][Full Text] [Related]
3. Drug disposition in cystic fibrosis.
Rey E; Tréluyer JM; Pons G
Clin Pharmacokinet; 1998 Oct; 35(4):313-29. PubMed ID: 9812180
[TBL] [Abstract][Full Text] [Related]
4. Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.
Hedman A; Alván G; Strandvik B; Arvidsson A
Clin Pharmacokinet; 1990 Feb; 18(2):168-75. PubMed ID: 2180614
[TBL] [Abstract][Full Text] [Related]
5. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.
de Groot R; Smith AL
Clin Pharmacokinet; 1987 Oct; 13(4):228-53. PubMed ID: 3311531
[TBL] [Abstract][Full Text] [Related]
7. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF
Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937
[TBL] [Abstract][Full Text] [Related]
9. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
Wang JP; Unadkat JD; al-Habet SM; O'Sullivan TA; Williams-Warren J; Smith AL; Ramsey B
Clin Pharmacol Ther; 1993 Sep; 54(3):293-302. PubMed ID: 8375124
[TBL] [Abstract][Full Text] [Related]
10. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions.
Kearns GL
Ann Pharmacother; 1993 Jan; 27(1):74-9. PubMed ID: 8431626
[TBL] [Abstract][Full Text] [Related]
11. Altered disposition of fleroxacin in patients with cystic fibrosis.
Mimeault J; Vallée F; Seelmann R; Sörgel F; Ruel M; LeBel M
Clin Pharmacol Ther; 1990 May; 47(5):618-28. PubMed ID: 2111750
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies of pediatric malabsorption syndromes].
Hosoyamada T
Fukuoka Igaku Zasshi; 2006 Nov; 97(11):322-50. PubMed ID: 17228786
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of vancomycin in adult cystic fibrosis patients.
Pleasants RA; Michalets EL; Williams DM; Samuelson WM; Rehm JR; Knowles MR
Antimicrob Agents Chemother; 1996 Jan; 40(1):186-90. PubMed ID: 8787903
[TBL] [Abstract][Full Text] [Related]
14. Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.
Hedman A; Adan-Abdi Y; Alvan G; Strandvik B; Arvidsson A
Clin Pharmacokinet; 1988 Jul; 15(1):57-65. PubMed ID: 3042246
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics in the elderly.
Crooks J; O'Malley K; Stevenson IH
Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.
De Sutter PJ; Gasthuys E; Van Braeckel E; Schelstraete P; Van Biervliet S; Van Bocxlaer J; Vermeulen A
Clin Pharmacokinet; 2020 Dec; 59(12):1551-1573. PubMed ID: 32808233
[TBL] [Abstract][Full Text] [Related]
17. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
[TBL] [Abstract][Full Text] [Related]
18. Cloxacillin absorption and disposition in cystic fibrosis.
Spino M; Chai RP; Isles AF; Thiessen JJ; Tesoro A; Gold R; MacLeod SM
J Pediatr; 1984 Nov; 105(5):829-35. PubMed ID: 6502318
[TBL] [Abstract][Full Text] [Related]
19. Gastric intrinsic factor hypersecretion stimulated by pentagastrin in cystic fibrosis.
Naimi D; Guéant JL; Hambaba L; Vidailhet M; Monin B; Nicolas JP
J Pediatr Gastroenterol Nutr; 1987; 6(6):899-903. PubMed ID: 3681575
[TBL] [Abstract][Full Text] [Related]
20. Disposition of drugs in cystic fibrosis. I. Sulfamethoxazole and trimethoprim.
Hutabarat RM; Unadkat JD; Sahajwalla C; McNamara S; Ramsey B; Smith AL
Clin Pharmacol Ther; 1991 Apr; 49(4):402-9. PubMed ID: 2015729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
